Outrageous Amounts Of Mercury
Being Injected Into Children

Vaccine Facts

This article may be of interest to you as I am sure we are all concerned as to what our children are being, injected with, as responsible parents and grand-parents there is a NEED TO KNOW. Rather frightening don't you think? No wonder the Prime Minister of England refused to have his child immunised... ___
One hundred years ago, children received 1 vaccine (the smallpox vaccine). Forty years ago, children received 5 vaccines routinely (diphtheria, pertussis, tetanus, polio, and smallpox vaccines) and as many as 8 shots by 2 years of age.
Children now receive 52 vaccines, in the form of 15 shots, by the time they are 6 months of age if they receive all the recommend shots, including the Prevnar pediatric pneumonia shot.
Vaccines contain THIMERSOL (mercury), MSG, aluminum, formaldehyde, sucrose and phenoxyethanol, which is antifreeze, among many other things.
Thimerosal, a vaccine ingredient, is nearly 50% mercury.
Mercury is a NEUROTOXIN.
EPA 'safe' levels are: .1 microgram per 1.0 kilogram of body weight per day.
Vaccines contain 12.5 to 25.0 micrograms of mercury, and a 'well baby' visit can see your child have between 50 and 62.5 mcgs of MERCURY injected into their bloodstream.
The CDC (US) has found a trend linking autism to mercury laden vaccines.
Thimerosal is a registered pesticide with the Department of Pesticide Registration of the Environmental Protection Agency.
Vaccines given:
Day of Birth: Hepatitis B Contains 12 mcg mercury which is 30 times above the 'safe' level
At 4 Months: DTaP and HiB on same day These contain 50 mcg mercury which is 60 times above the 'safe' level
At 6 Months: Hep B, Polio These contain 62.5 mcg mercury which is 78 times above the 'safe' level
At 15 Months, the child receives another 50 mcg mercury which is 41 times above the 'safe' level.
Low levels of mercury during critical stages of development have been associated with neurological disorders in children including ADD learning difficulties, Autism and speech delays.
Wonder why we have an epidemic of these conditions? As of 2001, up to twenty-four vaccines are recommended from birth to eighteen years. ___
This schedule indicates the recommended ages for routine administration of currently licensed childhood vaccines, as of December 1, 2001, for children through age 18 years. Any dose not given at the recommended age should be given at any subsequent visit when indicated and feasible.
1. Hepatitis B vaccine (Hep B). All infants should receive the first dose of hepatitis B vaccine soon after birth and before hospital discharge; the first dose may also be given by age 2 months if the infant,s mother is HBsAg-negative. Only monovalent hepatitis B vaccine can be used for the birth dose. Monovalent or combination vaccine containing Hep B may be used to complete the series; four doses of vaccine may be administered if combination vaccine is used. The second dose should be given at least 4 weeks after the first dose, except for Hib-containing vaccine which cannot be administered before age 6 weeks. The third dose should be given at least 16 weeks after the first dose and at least 8 weeks after the second dose. The last dose in the vaccination series (third or fourth dose) should not be administered before age 6 months.
Infants born to HBsAg-positive mothers should receive hepatitis B vaccine and 0.5 mL hepatitis B immune globulin (HBIG) within 12 hours of birth at separate sites. The second dose is recommended at age 1-2 months and the vaccination series should be completed (third or fourth dose) at age 6 months.
Infants born to mothers whose HBsAg status is unknown should receive the first dose of the hepatitis B vaccine series within 12 hours of birth. Maternal blood should be drawn at the time of delivery to determine the mother,s HBsAg status; if the HBsAg test is positive, the infant should receive HBIG as soon as possible (no later than age 1 week).
2. Diphtheria and tetanus toxoids and acellular pertussis vaccine (DTaP). The fourth dose of DTaP may be administered as early as age 12 months, provided 6 months have elapsed since the third dose and the child is unlikely to return at age 15-18 months. Tetanus and diphtheria toxoids (Td) is recommended at age 11-12 years if at least 5 years have elapsed since the last dose of tetanus and diphtheria toxoid-containing vaccine. Subsequent routine Td boosters are recommended every 10 years.
3. Haemophilus influenzae type b (Hib) conjugate vaccine. Three Hib conjugate vaccines are licensed for infant use. If PRP-OMP (PedvaxHIB ® or ComVax ® [Merck]) is administered at ages 2 and 4 months, a dose at age 6 months is not required. DTaP/Hib combination products should not be used for primary immunization in infants at ages 2, 4 or 6 months, but can be used as boosters following any Hib vaccine.
4. Inactivated polio vaccine (IPV). An all-IPV schedule is recommended for routine childhood polio vaccination in the United States. All children should receive four doses of IPV at ages 2 months, 4 months, 6-18 months, and 4-6 years.
5. Measles, mumps, and rubella vaccine (MMR). The second dose of MMR is recommended routinely at age 4-6 years but may be administered during any visit, provided at least 4 weeks have elapsed since the first dose and that both doses are administered beginning at or after age 12 months. Those who have not previously received the second dose should complete the schedule by the 11-12 year old visit.
6. Varicella vaccine. Varicella vaccine is recommended at any visit at or after age 12 months for susceptible children, i.e. those who lack a reliable history of chickenpox. Susceptible persons aged >13 years should receive two doses, given at least 4 weeks apart.
7. Pneumococcal vaccine. The heptavalent pneumococcal conjugate vaccine (PCV) is recommended for all children age 2-23 months. It is also recommended for certain children age 24-59 months. Pneumococcal polysaccharide vaccine (PPV) is recommended in addition to PCV for certain high-risk groups. See MMWR. 2000;49(RR-9):1-35.
8. Hepatitis A vaccine. Hepatitis A vaccine is recommended for use in selected states and regions, and for certain high-risk groups; consult your local public health authority. See MMWR. 1999;48(RR-12):1-37.
9. Influenza vaccine. Influenza vaccine is recommended annually for children age > 6 months with certain risk factors (including but not limited to asthma, cardiac disease, sickle cell disease, HIV, diabetes; see MMWR. 2001;50(RR-4):1- 44), and can be administered to all others wishing to obtain immunity. Children aged <12 years should receive vaccine in a dosage appropriate for their age (0.25 mL if age 6-35 months or 0.5 mL if age >3 years). Children aged <8 years who are receiving influenza vaccine for the first time should receive two doses separated by at least 4 weeks.
For additional information about vaccines, vaccine supply, and contraindications for immunization, please visit the National Immunization Program Web site at or call the National Immunization Hotline at (800) 232-2522 (English) or (800) 232-0233 (Spanish).


This Site Served by TheHostPros